Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.

There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

R8,2-million boost for UFS Qwaqwa campus
2005-01-21

The management of the University of the Free State (UFS) has approved an allocation of R6,8-mililon for upgrading of residences and R1,4-million for other upgrading of the UFS Qwaqwa campus.

According to the Head of the Qwaqwa campus, Prof Peter Mbati, the management also decided that a maintenance manager should be appointed, who will be responsible for dealing with routine maintenance on the Qwaqwa campus.

Prof Mbati said these developments were a major step forward for the Qwaqwa campus as it once again showed management’s commitment to the campus which was incorporated into the UFS in January 2003.

“We can systematically begin to tackle the huge backlog of needs – in terms of maintenance and upgrading – that has built up over many years.

“The new maintenance manager – once appointed – will also ensure that we shorten the turn-around time for addressing routine maintenance issues and in this way improve service delivery on this campus.

“This is not just a financial boost for the campus but I view it as a major boost for staff and student morale. With this commitment from management, staff and students should also commit themselves to the future of this campus,” Prof Mbati said.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept